The revised joint guidelines

This publication has 16 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
  Atherosclerosis, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
  Circulation, 1998
• Management of Dyslipidemia in Adults With Diabetes
  Diabetes Care, 1998
• Dyslipidemia, morbidity, and mortality in non-insulin-dependent diabetes mellitus: Lipoproteins and coronary heart disease in non-insulin-dependent diabetes mellitus
  Journal of Diabetes and its Complications, 1997
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Prevention of coronary heart disease in clinical practice
  European Heart Journal, 1994
• In search of how people change: Applications to addictive behaviors.
  American Psychologist, 1992
• Diabetes and atherosclerosis: An epidemiologic view
  Diabetes/Metabolism Research and Reviews, 1987